These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 29264740)

  • 1. CTLA-4 polymorphisms are associated with treatment outcomes of patients with multiple myeloma receiving bortezomib-based regimens.
    Qin XY; Lu J; Li GX; Wen L; Liu Y; Xu LP; Chang YJ; Liu KY; Jiang ZF; Huang XJ
    Ann Hematol; 2018 Mar; 97(3):485-495. PubMed ID: 29264740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphisms of nuclear factor-κB family genes are associated with development of multiple myeloma and treatment outcome in patients receiving bortezomib-based regimens.
    Du J; Huo J; Shi J; Yuan Z; Zhang C; Fu W; Jiang H; Yi Q; Hou J
    Haematologica; 2011 May; 96(5):729-37. PubMed ID: 21228035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphism of IL-10 receptor β affects the prognosis of multiple myeloma patients treated with thalidomide and/or bortezomib.
    Kasamatsu T; Saitoh T; Ino R; Gotoh N; Mitsui T; Shimizu H; Matsumoto M; Sawamura M; Yokohama A; Handa H; Tsukamoto N; Murakami H
    Hematol Oncol; 2017 Dec; 35(4):711-718. PubMed ID: 27405747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CTLA-4 polymorphisms and haplotype correlate with survival in ALL after allogeneic stem cell transplantation from related HLA-haplotype-mismatched donor.
    Qin XY; Wang Y; Li GX; Qin YZ; Wang FR; Xu LP; Chen H; Han W; Wang JZ; Zhang XH; Chang YJ; Liu KY; Jiang ZF; Huang XJ
    J Transl Med; 2016 Apr; 14():100. PubMed ID: 27118383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PDCD1 and PDCD1LG1 polymorphisms affect the susceptibility to multiple myeloma.
    Kasamatsu T; Awata M; Ishihara R; Murakami Y; Gotoh N; Matsumoto M; Sawamura M; Yokohama A; Handa H; Tsukamoto N; Saitoh T; Murakami H
    Clin Exp Med; 2020 Feb; 20(1):51-62. PubMed ID: 31620907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CTLA4 gene polymorphisms influence the incidence of infection after renal transplantation in Chinese recipients.
    Guo Y; Guo F; Wei C; Qiu J; Liu Y; Fang Y; Gao J
    PLoS One; 2013; 8(8):e70824. PubMed ID: 24015180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphisms and Circulating Plasma Protein Levels of Immune Checkpoints (CTLA-4 and PD-1) Are Associated With Posner-Schlossman Syndrome in Southern Chinese.
    Huang X; Liu X; Ye Y; Zhang T; Mei S; Zhu T; Peng S; Cai J; Yan Z; Zeng K; Nie D; Sun L; Hou X; Zhao J
    Front Immunol; 2021; 12():607966. PubMed ID: 33717091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Association of CTLA-4 gene polymorphisms with the genetic susceptibility and prognosis of patients with Bladder urothelial carcinoma].
    Li J; Zhang L; Xie H; Ge Y; Wang L
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2024 Aug; 41(8):988-993. PubMed ID: 39097285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD28/CTLA-4/ICOS haplotypes confers susceptibility to Graves' disease and modulates clinical phenotype of disease.
    Pawlak-Adamska E; Frydecka I; Bolanowski M; Tomkiewicz A; Jonkisz A; Karabon L; Partyka A; Nowak O; Szalinski M; Daroszewski J
    Endocrine; 2017 Jan; 55(1):186-199. PubMed ID: 27638540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytotoxic T-lymphocyte antigen 4 gene polymorphism influences the incidence of symptomatic human cytomegalovirus infection after renal transplantation.
    Misra MK; Pandey SK; Kapoor R; Sharma RK; Agrawal S
    Pharmacogenet Genomics; 2015 Jan; 25(1):19-29. PubMed ID: 25356901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of CTLA-4 polymorphisms with increased risks of myasthenia gravis.
    Li F; Yuan W; Wu X
    Ann Hum Genet; 2018 Nov; 82(6):358-369. PubMed ID: 30009380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of CTLA-4 gene polymorphism with end-stage renal disease and renal allograft outcome.
    Misra MK; Kapoor R; Pandey SK; Sharma RK; Agrawal S
    J Interferon Cytokine Res; 2014 Mar; 34(3):148-61. PubMed ID: 24313821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CTLA-4 and CD28 genes' polymorphisms and renal cell carcinoma susceptibility in the Polish population--a prospective study.
    Tupikowski K; Partyka A; Kolodziej A; Dembowski J; Debinski P; Halon A; Zdrojowy R; Frydecka I; Karabon L
    Tissue Antigens; 2015 Nov; 86(5):353-61. PubMed ID: 26403483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence of Association between CTLA-4 Gene Polymorphisms and Colorectal Cancers in Saudi Patients.
    Al-Harbi N; Abdulla MH; Vaali-Mohammed MA; Bin Traiki T; Alswayyed M; Al-Obeed O; Abid I; Al-Omar S; Mansour L
    Genes (Basel); 2023 Apr; 14(4):. PubMed ID: 37107632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PTPN22 and CTLA-4 Polymorphisms Are Associated With Polyglandular Autoimmunity.
    Houcken J; Degenhart C; Bender K; König J; Frommer L; Kahaly GJ
    J Clin Endocrinol Metab; 2018 May; 103(5):1977-1984. PubMed ID: 29409002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CTLA-4 polymorphisms and predisposition to digestive system malignancies: a meta-analysis of 31 published studies.
    Li J; Wang W; Sun Y; Zhu Y
    World J Surg Oncol; 2020 Mar; 18(1):55. PubMed ID: 32178688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytotoxic T-lymphocyte antigen 4 (CTLA4) +49AG and CT60 gene polymorphisms in Alopecia Areata: a case-control association study in the Italian population.
    Megiorni F; Mora B; Maxia C; Gerardi M; Pizzuti A; Rossi A
    Arch Dermatol Res; 2013 Sep; 305(7):665-70. PubMed ID: 23567921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Five Snps in Cytotoxic T-Lymphocyte Antigen 4 and Cancer Susceptibility: Evidence from 67 Studies.
    Fang M; Huang W; Mo D; Zhao W; Huang R
    Cell Physiol Biochem; 2018; 47(1):414-427. PubMed ID: 29794444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytotoxic T-lymphocyte antigen-4 polymorphisms and susceptibility to osteosarcoma.
    Liu Y; He Z; Feng D; Shi G; Gao R; Wu X; Song W; Yuan W
    DNA Cell Biol; 2011 Dec; 30(12):1051-5. PubMed ID: 21612409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of CTLA-4 gene polymorphisms on long-term kidney allograft function in Han Chinese recipients.
    Guo Y; Gao J; Gao S; Shang M; Guo F
    Oncotarget; 2016 Apr; 7(17):23088-95. PubMed ID: 27081086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.